Align Technology (NSDQ:ALGN) announced it has agreed to acquire dental software company Exocad (Darmstadt, Germany) for approximately $420 million in cash. The move will add Exocad’s experience in restorative dentistry, implantology, guided surgery and design to Align’s technology portfolio, which includes Invisalign clear-aligner orthodontic and iTero digital solutions. Exocad will also bring nearly 200 digital dentistry […]
Owens & Minor shares down 20% on mixed Q4 results
Owens & Minor (NYSE:OMI) posted fourth-quarter results today that beat the earnings consensus on Wall Street but missed on earnings. The Mechanicsville, Va.-based company reported losses of -$39 million, or -65¢ per share, on sales of $2.2 million for the three months ended Dec. 31, 2019, for a bottom-line sales loss of -10% compared with Q4 […]
How to prepare your medical device company for an exit
It’s about sticking to the basics, growing — and much more. One of Greenberg Traurig’s top corporate lawyers shares his insights about leading a medical device company to an acquisition or IPO. As co-chair Greenberg Traurig’s Global Life Sciences and Medical Technology Group and Co-Chair of the firm’s Atlanta Corporate and Securities Group, Wayne Elowe focuses […]
TransMedics down on missed Q4 projections
TransMedics (NSDQ:TMDX) shares dipped today on fourth-quarter results that came up short of the consensus forecast. The Andover, Mass.–based company posted losses of -$9.2 million, or -43¢ per share, on sales of $6.1 million for the three months ended Dec. 31, 2019, for a 20.2% bottom-line slide on sales growth of 70.9%. Adjusted to exclude one-time […]
Conformis down on mixed Q4 results
Conformis (NSDQ:CFMS) shares took a hit today on fourth-quarter results that beat the consensus forecast on earnings but came up just shy on sales. The Billerica, Mass–based orthopedic device maker posted losses of -$5.4 million, or -8¢ per share, on sales of $19.89 million for the three months ended Dec. 31, 2019, for a more than […]
Neuronetics stocks up on Street-beating Q4 results
Neuronetics (NSDQ:STIM) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Malvern, Penn.-based company reported profits of $3 million, or -41¢ per share, on sales of $17.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 11% compared with Q4 2018. Earnings per share were […]
Livongo beats The Street in Q4 results
Livongo Health (NSDQ:LVGO) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Mountain View, Calif.-based company reported losses of -$6 million, or -6¢ per share, on sales of $50.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 137.5% compared with Q4 2018. Adjusted to […]
Dentsply Sirona beats Street on 4Q sales, misses on earnings
Dentsply Sirona (NSDQ:XRAY) shares took a marginal dip today on fourth-quarter results that had mixed results compared to the consensus forecast. The York, Pa.–based dental equipment maker posted profits of $102 million, or 46¢ per share, on sales of $1.1 billion for the three months ended Dec. 31, 2019, for a monstrous bottom-line gain from […]
iRhythm Technologies beats on revenue, misses on earnings in Q4 results
iRhythm Technologies (NSDQ:IRTC) posted fourth-quarter results today that beat the revenue consensus on Wall Street but missed on earnings. The San Francisco-based company reported losses of $17.3 million, or -65¢ per share, on sales of $59.1 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 41.5% compared with Q4 2018. […]
Glaukos down despite Street-beating Q4
Glaukos (NYSE:GKOS) shares plummeted today despite fourth-quarter results that beat the consensus forecast. GKOS shares dropped down -27.4% at $44.60 per share in early-morning trading today. The San Clemente, Calif.–based ophthalmic medical technology and pharmaceutical company posted profits of $36.6 million, or 84¢ per share, on sales of $65.8 million for the three months ended Dec. […]
ICU Medical posts wider-than-forecast losses in Q4 results
ICU Medical (NSDQ:ICUI) posted fourth-quarter results today that beat the revenue consensus on Wall Street but missed on earnings. The San Clemente, Calif.-based company reported profits of $20.6 million, or 96¢ per share, on sales of $315.5 million for the three months ended Dec. 31, 2019, for a bottom-line sales loss of -7.3% compared with Q4 […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 566
- Next Page »
